Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-EIF4ERx (formerly LY2275796)

Also known as: eIF4E binding protein 2 antisense (eIF-4E ASO)

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionSecond-generation antisense compound targeting eukaryotic translation initiation factor 4E (eIF4E)
Molecular Target Eukaryotic translation initiation factor 4E (eIF4E)
Mechanism of ActionAntisense therapy
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today